FIELD: medicine.
SUBSTANCE: method involves introducing one or more desensitizing virus doses in turn in single cycle, followed by introducing one or more greater doses of virus. The virus is a negative filiform RNA virus. Virus quantity available in the second and any following desensitizing dose is to be greater than virus quantity in the preceding desensitizing dose. Virus quantity available in each of one or more increased doses is to be higher than virus quantity in each desensitizing dose.
EFFECT: minimized adverse side effects.
20 cl, 4 tbl
